Se connecter Inscription gratuite

Cotinga Pharmaceuticals Float d'actions

Quel est le Float d'actions de Cotinga Pharmaceuticals?

Le Float d'actions de Cotinga Pharmaceuticals, Inc. est 20.511M 93.29%

Quelle est la définition de Float d'actions ?

Le flottant des actions est la partie des actions d’une société qui est entre les mains d’investisseurs publics, par opposition aux actions immobilisées.

Shares float represents the portion of shares of a corporation that are in the hands of public investors as opposed to locked-in stock held by promoters, company officers, controlling-interest investors, or government. This number is sometimes seen as a better way of calculating market capitalization because it provides a more accurate reflection of what public investors consider the company to be worth. In this context, the float may refer to all the shares outstanding that can be publicly traded

The float is calculated by subtracting the locked-in shares from outstanding shares. Stocks with smaller floats tend to be more volatile than those with larger floats. In general, the large holdings of founding shareholders, corporate cross-holdings, and government holdings in partially privatized companies are excluded when calculating the size of a public float.

Float d'actions des entreprises dans Health Care secteur sur TSXV par rapport à Cotinga Pharmaceuticals

Que fait Cotinga Pharmaceuticals?

Cotinga Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer and other unmet medical needs. The company's lead compound is COTI-2, an oral small molecule targeting p53 a tumor suppressor gene. It also develops COTI-219, an oral small molecule compound targeting the mutant forms of KRAS without inhibiting normal KRAS functions. Cotinga Pharmaceuticals Inc. has a research collaboration with St. Vincent's University Hospital to evaluate COTI-2 in combination with eribulin in patients with triple negative metastatic breast cancer. The company was formerly known as Critical Outcome Technologies Inc. and changed its name to Cotinga Pharmaceuticals Inc. in January 2018. Cotinga Pharmaceuticals Inc. is based in Toronto, Canada.

Entreprises avec float d'actions similaire à Cotinga Pharmaceuticals